Why the study?
Does natriuretic peptide testing guide therapy and improve management in patients with heart failure?
Does natriuretic peptide testing guide therapy and improve management in patients with heart failure?
This review highlights the established role of BNP/NT-proBNP in acute heart failure and its emerging potential to guide therapy in chronic stable heart failure.
Answers are grounded in this paper and cite their sources.
Supports established acute HF use; leaves open whether natriuretic peptide guidance improves chronic outpatient outcomes.
BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
No takes yet. Share an insight, caveat, or question.
Mohammed et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: